Amryt Pharma Plc Asset Turnover Ratio (AMYT), as of fourth quarter 2021, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Amryt Pharma Plc  (NASDAQ: AMYT)
 

Amryt Pharma Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Amryt Pharma Plc asset turnover ratio, the ability of Amryt Pharma Plc's assets to generate revenue in the fourth quarter 2021, increased sequentially to 0.24 in the fourth quarter (Dec 31 2021), yet the ratio remained below the average, as AMYT's position remain challenging.

Within sector 245 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2021 compared to the preceding quarter from 0 to 3843.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AMYT Asset Turnover Ratio (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Asset Change 150.67 % 57.44 % - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.24 - - - -
AMYT's Total Ranking # 3843 # 0 # 0 # 0 #
Seq. Asset Change 61.24 % 0 % 0 % 55.46 % 1.27 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 246
Healthcare Sector # 615
Overall Market # 3843

Asset Turnover Ratio Statistics
High Average Low
1.89 1.89 1.89
(Dec 31 2021)  




AMYT Company Profile • Back to AMYT Efficiency Comparisons • Compare AMYT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2021 Assets at quarter ending Dec 31 2021
Bio techne Corp  0.46 $ 1,029.575  Millions$ 2,220.186  Millions
Steris Plc  0.46 $ 4,247.909  Millions$ 9,250.599  Millions
Evolus Inc   0.46 $ 99.673  Millions$ 217.441  Millions
Coherus Oncology inc   0.46 $ 326.551  Millions$ 713.476  Millions
Biogen Inc   0.46 $ 10,981.700  Millions$ 24,002.275  Millions
Avanos Medical Inc   0.46 $ 744.600  Millions$ 1,631.150  Millions
Biohaven Ltd   0.46 $ 462.509  Millions$ 1,014.365  Millions
Dentsply Sirona Inc   0.46 $ 4,222.000  Millions$ 9,260.750  Millions
Intuitive Surgical Inc   0.45 $ 5,710.100  Millions$ 12,581.750  Millions
Neuronetics Inc   0.45 $ 58.443  Millions$ 128.814  Millions
Syndax Pharmaceuticals Inc   0.45 $ 139.709  Millions$ 307.973  Millions
Standard Biotools Inc   0.45 $ 130.581  Millions$ 287.979  Millions
Sol gel Technologies Ltd   0.45 $ 31.272  Millions$ 69.189  Millions
Livanova Plc  0.45 $ 1,035.365  Millions$ 2,292.513  Millions
Ati Physical Therapy Inc   0.45 $ 627.871  Millions$ 1,390.778  Millions
Immucell Corporation  0.45 $ 19.243  Millions$ 43.012  Millions
Neptune Wellness Solutions Inc   0.45 $ 59.922  Millions$ 134.140  Millions
Si bone inc   0.45 $ 90.152  Millions$ 201.891  Millions
Biocryst Pharmaceuticals Inc   0.44 $ 157.170  Millions$ 353.907  Millions
Revvity Inc  0.44 $ 5,067.169  Millions$ 11,556.450  Millions
Seres Therapeutics Inc   0.44 $ 144.927  Millions$ 331.624  Millions
Novavax inc   0.44 $ 1,146.290  Millions$ 2,625.162  Millions
Ironwood Pharmaceuticals inc   0.43 $ 413.753  Millions$ 953.215  Millions
Heska Corporation  0.43 $ 253.739  Millions$ 587.551  Millions
Invo Fertility Inc   0.43 $ 4.160  Millions$ 9.683  Millions
Kaya Holdings Inc   0.43 $ 0.890  Millions$ 2.083  Millions
Valneva Se  0.43 $ 389.856  Millions$ 915.434  Millions
Scientific Industries Inc   0.43 $ 10.660  Millions$ 25.032  Millions
Innoviva Inc   0.42 $ 391.866  Millions$ 922.769  Millions
Atea Pharmaceuticals Inc   0.42 $ 351.367  Millions$ 832.147  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.